Point-of-Care Molecular Diagnostics Market Size, Share & Trends Report

Point-of-Care Molecular Diagnostics Market Size, Share & Trends Analysis Report By Application (Infectious Diseases, Oncology, Prenatal Testing), By Technology, By Test Location, By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: 978-1-68038-886-2
  • Number of Pages: 150
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2022
  • Industry: Healthcare

Market Segmentation

  • Global Point-of-Care Molecular Diagnostics Test Location Outlook (Revenue, USD Million, 2023 - 2030)
    • OTC
    • POC
  • Global Point-of-Care Molecular Diagnostics Application Type Outlook (Revenue, USD Million, 2023 - 2030)
    • Infectious Diseases
      • HIV POC
      • Clostridium difficile POC
      • HBV POC
      • Pneumonia or Streptococcus associated infections
      • Respiratory syncytial virus (RSV) POC
      • HPV POC
      • Influenza/Flu POC
      • HCV POC
      • MRSA POC
      • TB and drug-resistant TB POC
      • HSV POC
      • Other Infectious Diseases
    • Oncology
    • Hematology
    • Prenatal Testing
    • Endocrinology
    • Other Applications
  • Global Point-of-Care Molecular Diagnostics Technology Outlook (Revenue, USD Million, 2023 - 2030)
    • PCR-based
    • Genetic Sequencing-based
    • Hybridization-based
    • Microarray-based
  • Global Point-of-Care Molecular Diagnostics End-use Outlook (Revenue, USD Million, 2023 - 2030)
    • Decentralized Labs
    • Hospitals
    • Home-care
    • Assisted Living Healthcare Facilities
    • Other uses
  • Global Point-of-Care Molecular Diagnostics Regional Outlook (Revenue, USD Million, 2023 - 2030)
    • North America
      • North America Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
        • OTC
        • POC
      • North America Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
        • Infectious Diseases
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV POC
          • Other Infectious Diseases
        • Oncology
        • Hematology
        • Prenatal Testing
        • Endocrinology
        • Other Applications
      • North America Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
        • Decentralized Labs
        • Hospitals
        • Home-care
        • Assisted Living Healthcare Facilities
        • Other uses
      • North America Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
        • PCR-based
        • Genetic Sequencing-based
        • Hybridization-based
        • Microarray-based
      • U.S.
        • U.S. Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • U.S. Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • U.S. Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • U.S. Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Canada
        • Canada Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Canada Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Canada Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Canada Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
    • Europe
      • Europe Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
        • OTC
        • POC
      • Europe Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
        • Infectious Diseases
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV POC
          • Other Infectious Diseases
        • Oncology
        • Hematology
        • Prenatal Testing
        • Endocrinology
        • Other Applications
      • Europe Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
        • Decentralized Labs
        • Hospitals
        • Home-care
        • Assisted Living Healthcare Facilities
        • Other uses
      • Europe Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
        • PCR-based
        • Genetic Sequencing-based
        • Hybridization-based
        • Microarray-based
      • U.K.
        • U.K. Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • U.K. Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • U.K. Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • U.K. Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Germany
        • Germany Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Germany Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Germany Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Germany Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • France
        • France Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • France Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • France Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • France Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Italy
        • Italy Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Italy Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Italy Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Italy Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Spain
        • Spain Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Spain Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Spain Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Spain Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Norway
        • Norway Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Norway Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Norway Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Norway Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Denmark
        • Denmark Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Denmark Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Denmark Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Denmark Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Sweden
        • Sweden Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Sweden Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Sweden Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Sweden Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
    • Asia Pacific
      • Asia Pacific Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
        • OTC
        • POC
      • Asia Pacific Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
        • Infectious Diseases
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV POC
          • Other Infectious Diseases
        • Oncology
        • Hematology
        • Prenatal Testing
        • Endocrinology
        • Other Applications
      • Asia Pacific Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
        • Decentralized Labs
        • Hospitals
        • Home-care
        • Assisted Living Healthcare Facilities
        • Other uses
      • Asia Pacific Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
        • PCR-based
        • Genetic Sequencing-based
        • Hybridization-based
        • Microarray-based
      • Japan
        • Japan Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Japan Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Japan Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Japan Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • China
        • China Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • China Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • China Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • China Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • India
        • India Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • India Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • India Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • India Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based         
      • Australia
        • Australia Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Australia Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Australia Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Australia Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • South Korea
        • South Korea Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • South Korea Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • South Korea Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • South Korea Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Thailand
        • Thailand Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Thailand Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Thailand Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Thailand Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
    • Latin America
      • Latin America Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
        • OTC
        • POC
      • Latin America Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
        • Infectious Diseases
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV POC
          • Other Infectious Diseases
        • Oncology
        • Hematology
        • Prenatal Testing
        • Endocrinology
        • Other Applications
      • Latin America Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
        • Decentralized Labs
        • Hospitals
        • Home-care
        • Assisted Living Healthcare Facilities
        • Other uses
      • Latin America Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
        • PCR-based
        • Genetic Sequencing-based
        • Hybridization-based
        • Microarray-based
      • Brazil
        • Brazil Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Brazil Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Brazil Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Brazil Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Mexico
        • Mexico Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Mexico Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Mexico Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Mexico Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Argentina
        • Argentina Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Argentina Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Argentina Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Argentina Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
    • MEA
      • MEA Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
        • OTC
        • POC
      • MEA Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
        • Infectious Diseases
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV POC
          • Other Infectious Diseases
        • Oncology
        • Hematology
        • Prenatal Testing
        • Endocrinology
        • Other Applications
      • MEA Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
        • Decentralized Labs
        • Hospitals
        • Home-care
        • Assisted Living Healthcare Facilities
        • Other uses
      • MEA Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
        • PCR-based
        • Genetic Sequencing-based
        • Hybridization-based
        • Microarray-based
      • South Africa
        • South Africa Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • South Africa Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • South Africa Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • South Africa Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Saudi Arabia
        • Saudi Arabia Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Saudi Arabia Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Saudi Arabia Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Saudi Arabia Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • UAE
        • UAE Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • UAE Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • UAE Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • UAE Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based
      • Kuwait
        • Kuwait Point-of-Care Molecular Diagnostics Market, By Test Location 2023 - 2030 (USD Million)
          • OTC
          • POC
        • Kuwait Point-of-Care Molecular Diagnostics Market, By Application, 2023 - 2030 (USD Million)
          • Infectious Diseases
            • HIV POC
            • Clostridium difficile POC
            • HBV POC
            • Pneumonia or Streptococcus associated infections
            • Respiratory syncytial virus (RSV) POC
            • HPV POC
            • Influenza/Flu POC
            • HCV POC
            • MRSA POC
            • TB and drug-resistant TB POC
            • HSV POC
            • Other Infectious Diseases
          • Oncology
          • Hematology
          • Prenatal Testing
          • Endocrinology
          • Other Applications
        • Kuwait Point-of-Care Molecular Diagnostics Market, by End-use 2023 - 2030 (USD Million)
          • Decentralized Labs
          • Hospitals
          • Home-care
          • Assisted Living Healthcare Facilities
          • Other uses
        • Kuwait Point-of-Care Molecular Diagnostics Market, by Technology 2023 - 2030 (USD Million)
          • PCR-based
          • Genetic Sequencing-based
          • Hybridization-based
          • Microarray-based

Point-of-Care Molecular Diagnostics Market Dynamics

Driver: Introduction Of Technologically Advanced Products

Molecular microbiology has revolutionized virology, reducing Turnaround Times (TAT) from weeks to hours, enhancing viral detection specificity and sensitivity, and enabling viral load quantification. Molecular assays have also improved the diagnosis of non-culturable pathogens such as Toxoplasma gondii, Bartonella, and Leishmania. Advancements in miniaturization, nanotechnology, microfluidics, and cloud-connected POC diagnostics are making molecular-level diagnostics more affordable, user-friendly, and sensitive. Smartphone-integrated readers with diverse biosensing platforms enable onsite and on-time diagnostics. 3D printing enhances POC device fabrication and performance, while flexible sensors with wireless communication allow real-time patient monitoring for preventative healthcare and disease outbreaks. These innovations signify significant progress in POC molecular diagnostics and its potential impact on healthcare. In May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is further studied for conversion into a POC test. There is a shift in the industry dynamics, and an increasing number of players are focusing on launching tests for home-based tests. In June 2023, the partnership between the TB research team at St George's University of London, the Institute for Infection and Immunity, and QuantuMDx, a UK-based medical technology company, offers a unique opportunity to prioritize the development of a cost-effective, portable, accurate, and rapid TB diagnostic test. This collaboration combines academic researchers' expertise with the biotechnology industry's technological capabilities to address significant healthcare challenges, including TB. The chip-based technology being developed has the potential to provide accessible and timely TB diagnostics, benefiting suspected TB patients and contributing to the prevention of further disease spread. This partnership exemplifies the power of cross-sector collaborations in advancing innovative solutions for global health issues. Furthermore, POC molecular diagnostics combined with Artificial Intelligence (AI) has the potential to revolutionize healthcare by providing rapid & accurate diagnostic results, improving patient outcomes, and enhancing the overall efficiency of diagnostic processes.

Restraint: Presence Of Ambiguous Regulatory Framework

The regulatory framework for approvals has always posed major restraining factors in pharmaceutical, biotechnology, and medical technology industries. The possibility of harm to patients has driven the U.S. FDA premarketing guidelines. The regulatory atmosphere is already complex, and the FDA is becoming ever more careful as dependency on molecular diagnostics for making serious medical decisions is growing. The FDA also conducts postmarket investigations of IVD products to ensure parity between performance and claims. For instance, a heavy penalty was imposed on Nichols Institute, a subsidiary of Quest Diagnostics, due to the failure of its product to perform what was claimed. Hence, the stringency of regulations associated with the approval process for molecular diagnostics is limiting market growth. Moreover, increasing approval of rival technologies such as immunoassays and others due to technological advancements, POC, & automation in these technologies are affecting the market uptake of molecular diagnostics over the forecast period. For instance, in areas like sub-Saharan Africa, portable immunoassay technologies for diagnosing malaria, tuberculosis, West Nile virus, and other infectious diseases are vital for mitigating frequent disease outbreaks. In December 2022, BioMérieux announced the approval of its automated immunoassay system “Vidas Kube,” which can be used in critical care emergency settings for detection of infectious diseases, immunochemistry, and food pathogens. Such initiatives are expected to decrease the market growth over the forecast period.

Opportunity: Rising Need For Rapid Testing Solutions

Increasing demand for rapid testing solutions with high accuracy is anticipated to create opportunities for market players. Rapid detection of infection plays an important role in managing the disease and making treatment decisions. Currently, RT-PCR-based detection methods require more manpower and long processing time, which are expected to reduce the testing capacity of suspected cases. Other methods such as CT scan & culture methods do not offer fast detection and real-time analysis. Therefore, it is necessary to develop technologies that can increase testing capacity. For instance, real-time & digital PCR and other molecular diagnostic technologies take 30 minutes or more to detect infection, whereas results using plasmonic PCR are obtained within 6 minutes with high yield & sensitivity. PoC testing and robust PCR thermal cycler are expected to present manufacturers with growth opportunities. In addition, plasmonic PCR technology allows the development of innovative instrumentation, which can be used as a small handheld device for field work or large instruments required in hospitals. The platform uses nanoheaters to monitor and manage an ultrafast diagnosis. For instance, in July 2022, a new, low-cost test technology, which provides results in 23 minutes, was developed by researchers at Columbia Engineering and Rover Diagnostic. Hence, an instant “red flag” for infection is achievable with complete testing within minutes. Hence, technologically advanced tests have a high opportunity to fulfill unmet needs over the forecast period. In addition, launch of novel molecular diagnostic tests is expected to boost the market of molecular diagnostic technology owing to label-free real-time monitoring of amplicon, reduced detection time, and low cost required to detect infection.

What Does This Report Include?

This section will provide insights into the contents included in this point-of-care molecular diagnostics market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Point-of-care molecular diagnostics market qualitative analysis

  • Industry overview

  • Industry trends

  • Market drivers and restraints

  • Market size

  • Growth prospects

  • Porter’s analysis

  • PESTEL analysis

  • Key market opportunities prioritized

  • Competitive landscape

    • Company overview

    • Financial performance

    • Product benchmarking

    • Latest strategic developments

Point-of-care molecular diagnostics market quantitative analysis

  • Market size, estimates, and forecast from 2023 to 2030

  • Market estimates and forecast for product segments up to 2030

  • Regional market size and forecast for product segments up to 2030

  • Market estimates and forecast for application segments up to 2030

  • Regional market size and forecast for application segments up to 2030

  • Company financial performance

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon